A chimeric adenovirus‐vectored vaccine based on Beta spike and Delta RBD confers a broad‐spectrum neutralization against Omicron‐included SARS‐CoV‐2 variants.
- Resource Type
- Article
- Source
- MedComm; May2024, Vol. 5 Issue 5, p1-16, 16p
- Subject
ADENOVIRUS diseases SARS-CoV-2 SARS-CoV-2 Delta variant SARS-CoV-2 Omicron variant IMMUNOLOGIC memory VACCINES - Language
- ISSN
- 26882663